86418815 - TOLERO PHARMACEUTICALS

Information

  • Trademark
  • 86418815
  • Serial Number
    86418815
  • Registration Number
    4751574
  • Filing Date
    October 08, 2014
    10 years ago
  • Registration Date
    June 09, 2015
    9 years ago
  • Transaction Date
    January 18, 2022
    3 years ago
  • Status Date
    December 10, 2021
    3 years ago
  • Published for Opposition Date
    March 24, 2015
    9 years ago
  • Location Date
    June 09, 2015
    9 years ago
  • First Use Anywhere Date
    August 01, 2011
    13 years ago
  • First Use In Commerce Date
    August 01, 2011
    13 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BUSH, KAREN K
  • Attorney Docket Number
    20739
    Attorney Name
    Howard N. Aronson
    Law Office Assigned Location Code
    L80
  • Owners
Mark Drawing Code
4000
Mark Identification
TOLERO PHARMACEUTICALS
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: "PHARMACEUTICALS"
  • GS0421: Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of new technology for others in the field of pharmacology; Development of pharmaceutical preparations and medicines; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of pharmacology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of pharmacology; Medical and scientific research information in the field of pharmacology; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the field of genetics and genetic engineering; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Working on and evaluation of chemical analyses; Working on and evaluation of chemical syntheses
Case File Event Statements
  • 12/10/2021 - 3 years ago
    19 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 6/9/2020 - 4 years ago
    18 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 2/9/2018 - 7 years ago
    17 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/9/2018 - 7 years ago
    16 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/13/2017 - 7 years ago
    15 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 6/9/2015 - 9 years ago
    14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/24/2015 - 9 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/24/2015 - 9 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/4/2015 - 9 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/14/2015 - 10 years ago
    10 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/13/2015 - 10 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 1/27/2015 - 10 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/27/2015 - 10 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/27/2015 - 10 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/27/2015 - 10 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/27/2015 - 10 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/27/2015 - 10 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/15/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 10/11/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP